3D chromatin architecture and epigenetic regulation in cancer stem cells

Abstract

Dedifferentiation of cell identity to a progenitor-like or stem cell-like state with increased cellular plasticity is frequently observed in cancer formation. During this process, a subpopulation of cells in tumours acquires a stem cell-like state partially resembling to naturally occurring pluripotent stem cells that are temporarily present during early embryogenesis. Such characteristics allow these cancer stem cells (CSCs) to give rise to the whole tumour with its entire cellular heterogeneity and thereby support metastases formation while being resistant to current cancer therapeutics. Cancer development and progression are demarcated by transcriptional dysregulation. In this article, we explore the epigenetic mechanisms shaping gene expression during tumorigenesis and cancer stem cell formation, with an emphasis on 3D chromatin architecture. Comparing the pluripotent stem cell state and epigenetic reprogramming to dedifferentiation in cellular transformation provides intriguing insight to chromatin dynamics. We suggest that the 3D chromatin architecture could be used as a target for re-sensitizing cancer stem cells to therapeutics.

Keywords

chromatin architecture / 3D chromatin topology / epigenetics / tumorigenesis / cancer stem cells / pluripotent stem cells

References

[1] Adam RC, Yang H, Rockowitz S, Larsen SB, Nikolova M, Oristian DS, Polak L, Kadaja M, Asare A, Zheng D (2015) Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521:366–370

[2] Ahmed K, Dehghani H, Rugg-Gunn P, Fussner E, Rossant J, Bazett-Jones DP (2010) Global chromatin architecture reflects pluripotency and lineage commitment in the early mouse embryo. PLoS ONE 5:e10531

[3] Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, John RM, Gouti M, Casanova M, Warnes G, Merkenschlager M (2006) Chromatin signatures of pluripotent cell lines. Nat Cell Biol 8:532–538

[4] Bartman CR, Hsu SC, Hsiung CC, Raj A, Blobel GA (2016) Enhancer regulation of transcriptional bursting parameters revealed by forced chromatin looping. Mol Cell 62:237–247

[5] Bartova E, Krejci J, Harnicarova A, Kozubek S (2008a) Differentiation of human embryonic stem cells induces condensation of chromosome territories and formation of heterochromatin protein 1 foci. Differentiation 76:24–32

[6] Bartova E, Galiova G, Krejci J, Harnicarova A, Strasak L, Kozubek S (2008b) Epigenome and chromatin structure in human embryonic stem cells undergoing differentiation. Dev Dyn 237:3690–3702

[7] Beagan JA, Gilgenast TG, Kim J, Plona Z, Norton HK, Hu G, Hsu SC, Shields EJ, Lyu X, Apostolou E (2016) Local genome topology can exhibit an incompletely rewired 3D-folding state during somatic cell reprogramming. Cell Stem Cell 18:611–624

[8] Beagrie RA, Scialdone A, Schueler M, Kraemer DC, Chotalia M, Xie SQ, Barbieri M, de Santiago I, Lavitas LM, Branco MR (2017) Complex multi-enhancer contacts captured by genome architecture mapping. Nature 543:519–524

[9] Benabdallah NS, Williamson I, Illingworth RS, Kane L, Boyle S, Sengupta D, Grimes GR, Therizols P, Bickmore WA (2019) Decreased enhancer-promoter proximity accompanying enhancer activation. Mol Cell 76:473–484

[10] Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, Liu Y, Noushmehr H, Lange CP, van Dijk CM, Tollenaar RA (2011) Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 44:40–46

[11] Bertolini JA, Favaro R, Zhu Y, Pagin M, Ngan CY, Wong CH, Tjong H, Vermunt MW, Martynoga B, Barone C (2019) Mapping the global chromatin connectivity network for Sox2 function in neural stem cell maintenance. Cell Stem Cell 24:462–476

[12] Bhan S, Negi SS, Shao C, Glazer CA, Chuang A, Gaykalova DA, Sun W, Sidransky D, Ha PK, Califano JA (2011) BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer. Clin Cancer Res 17:4267–4276

[13] Cai Z, Cao C, Ji L, Ye R, Wang D, Xia C, Wang S, Du Z, Hu N, Yu X (2020) RIC-seq for global in situ profiling of RNA–RNA spatial interactions. Nature 582:432–437

[14] Chao HM, Huang HX, Chang PH, Tseng KC, Miyajima A, Chern E (2017) Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/betacatenin pathway. Oncotarget 8:2604–2616

[15] Cheema Z, Hari-Gupta Y, Kita GX, Farrar D, Seddon I, Corr J, Klenova E (2014) Expression of the cancer-testis antigen BORIS correlates with prostate cancer. Prostate 74:164–176

[16] Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, Liu Y, Reisfeld RA, Xiang R, Lv D (2012) SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS ONE 7:e36326

[17] Cheng J, Li W, Kang B, Zhou Y, Song J, Dan S, Yang Y, Zhang X, Li J, Yin S (2015) Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells. Nat Commun 6:7209

[18] Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelialmesenchymal transdifferentiation. Cancer Res 70:10433–10444

[19] D’Arcy V, Pore N, Docquier F, Abdullaev ZK, Chernukhin I, Kita GX, Rai S, Smart M, Farrar D, Pack S (2008) BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours. Br J Cancer 98:571–579

[20] Davidson IF, Bauer B, Goetz D, Tang W, Wutz G, Peters JM (2019) DNA loop extrusion by human cohesin. Science 366:1338–1345

[21] de Wit E, Bouwman BA, Zhu Y, Klous P, Splinter E, Verstegen MJ, Krijger PH, Festuccia N, Nora EP, Welling M (2013) The pluripotent genome in three dimensions is shaped around pluripotency factors. Nature 501:227–231

[22] Debruyne DN, Dries R, Sengupta S, Seruggia D, Gao Y, Sharma B, Huang H, Moreau L, McLane M, Day DS (2019) BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells. Nature 572:676–680

[23] Denholtz M, Bonora G, Chronis C, Splinter E, de Laat W, Ernst J, Pellegrini M, Plath K (2013) Long-range chromatin contacts in embryonic stem cells reveal a role for pluripotency factors and polycomb proteins in genome organization. Cell Stem Cell 13:602–616

[24] Di Giammartino DC, Kloetgen A, Polyzos A, Liu Y, Kim D, Murphy D, Abuhashem A, Cavaliere P, Aronson B, Shah V (2019) KLF4 is involved in the organization and regulation of pluripotencyassociated three-dimensional enhancer networks. Nat Cell Biol 21:1179–1190

[25] D’Ippolito AM, McDowell IC, Barrera A, Hong LK, Leichter SM, Bartelt LC, Vockley CM, Majoros WH, Safi A, Song L (2018) Pre-established chromatin interactions mediate the genomic response to glucocorticoids. Cell Syst 7:146–160

[26] Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B (2012) Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485:376–380

[27] Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, Ye Z, Kim A, Rajagopal N, Xie W (2015) Chromatin architecture reorganization during stem cell differentiation. Nature 518:331–336

[28] Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R, Herb B, Ladd-Acosta C, Rho J, Loewer S (2009) Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 41:1350–1353

[29] Dowen JM, Fan ZP, Hnisz D, Ren G, Abraham BJ, Zhang LN, Weintraub AS, Schujiers J, Lee TI, Zhao K (2014) Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 159:374–387

[30] Dunican DS, Mjoseng HK, Duthie L, Flyamer IM, Bickmore WA, Meehan RR (2020) Bivalent promoter hypermethylation in cancer is linked to the H327me3/H3K4me3 ratio in embryonic stem cells. BMC Biol 18:25

[31] Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, Bazett-Jones DP, Le Grice S, McKay RD, Buetow KH (2008) Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2:437–447

[32] Eskeland R, Leeb M, Grimes GR, Kress C, Boyle S, Sproul D, Gilbert N, Fan Y, Skoultchi AI, Wutz A (2010) Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol Cell 38:452–464

[33] Fang R, Yu M, Li G, Chee S, Liu T, Schmitt AD, Ren B (2016) Mapping of long-range chromatin interactions by proximity ligation-assisted ChIP-seq. Cell Res 26:1345–1348

[34] Fattet L, Jung HY, Matsumoto MW, Aubol BE, Kumar A, Adams JA, Chen AC, Sah RL, Engler AJ, Pasquale EB (2020) Matrix rigidity controls epithelial-mesenchymal plasticity and tumor metastasis via a mechanoresponsive EPHA2/LYN complex. Dev Cell 54:302–316

[35] Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21–33

[36] Finlan LE, Sproul D, Thomson I, Boyle S, Kerr E, Perry P, Ylstra B, Chubb JR, Bickmore WA (2008) Recruitment to the nuclear periphery can alter expression of genes in human cells. PLoS Genet 4:e1000039

[37] Fischedick G, Wu G, Adachi K, Arauzo-Bravo MJ, Greber B, Radstaak M, Kohler G, Tapia N, Iacone R, Anastassiadis K (2014) Nanog induces hyperplasia without initiating tumors. Stem Cell Res 13:300–315

[38] Flavahan WA, Gaskell E, Bernstein BE (2017) Epigenetic plasticity and the hallmarks of cancer. Science. https://doi.org/10.1126/science.aal2380

[39] Friedmann-Morvinski D, Verma IM (2014) Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep 15:244–253

[40] Friedmann-Morvinski D, Bushong EA, Ke E, Soda Y, Marumoto T, Singer O, Ellisman MH, Verma IM (2012) Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338:1080–1084

[41] Griessinger E, Moschoi R, Biondani G, Peyron JF (2017) Mitochondrial transfer in the leukemia microenvironment. Trends Cancer 3:828–839

[42] Grubert F, Srivas R, Spacek DV, Kasowski M, Ruiz-Velasco M, Sinnott-Armstrong N, Greenside P, Narasimha A, Liu Q, Geller B (2020) Landscape of cohesin-mediated chromatin loops in the human genome. Nature 583:737–743

[43] Guarda A, Bolognese F, Bonapace IM, Badaracco G (2009) Interaction between the inner nuclear membrane lamin B receptor and the heterochromatic methyl binding protein, MeCP2. Exp Cell Res 315:1895–1903

[44] Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, Lander ES (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146:633–644

[45] Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

[46] Hansen AS, Hsieh TS, Cattoglio C, Pustova I, Saldana-Meyer R, Reinberg D, Darzacq X, Tjian R (2019) Distinct classes of chromatin loops revealed by deletion of an RNA-binding region in CTCF. Mol Cell 76:395–411

[47] Harr JC, Luperchio TR, Wong X, Cohen E, Wheelan SJ, Reddy KL (2015) Directed targeting of chromatin to the nuclear lamina is mediated by chromatin state and A-type lamins. J Cell Biol 208:33–52

[48] Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA (2013) Super-enhancers in the control of cell identity and disease. Cell 155:934–947

[49] Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, Bradner JE, Young RA (2015) Convergence of developmental and oncogenic signaling pathways at transcriptional superenhancers. Mol Cell 58:362–370

[50] Hnisz D, Weintraub AS, Day DS, Valton AL, Bak RO, Li CH, Goldmann J, Lajoie BR, Fan ZP, Sigova AA (2016) Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science 351:1454–1458

[51] Hnisz D, Schuijers J, Li CH, Young RA (2018) Regulation and dysregulation of chromosome structure in cancer. Annu Rev Cancer Biol 2:21–40

[52] Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121:465–477

[53] Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S (2008) Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 68:6533–6540

[54] Johnson TG, Schelch K, Mehta S, Burgess A, Reid G (2019) Why be one protein when you can affect many? The multiple roles of YB- 1 in lung cancer and mesothelioma. Front Cell Dev Biol 7:221

[55] Johnstone SE, Reyes A, Qi Y, Adriaens C, Hegazi E, Pelka K, Chen JH, Zou LS, Drier Y, Hecht V (2020) Large-scale topological changes restrain malignant progression in colorectal cancer. Cell 182:1474–1489

[56] Joshi O, Wang SY, Kuznetsova T, Atlasi Y, Peng T, Fabre PJ, Habibi E, Shaik J, Saeed S, Handoko L (2015) Dynamic reorganization of extremely long-range promoter-promoter interactions between two states of pluripotency. Cell Stem Cell 17:748–757

[57] Kaufhold S, Garban H, Bonavida B (2016) Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication. J Exp Clin Cancer Res 35:84

[58] Kim Y, Shi Z, Zhang H, Finkelstein IJ, Yu H (2019) Human cohesin compacts DNA by loop extrusion. Science 366:1345–1349

[59] Knappe N, Novak D, Weina K, Bernhardt M, Reith M, Larribere L, Holzel M, Tuting T,Gebhardt C, Umansky V (2016) Directed dedifferentiation using partial reprogramming induces invasive phenotype in melanoma cells. Stem Cells 34:832–846

[60] Krijger PH, Di Stefano B, de Wit E, Limone F, van Oevelen C, de Laat W, Graf T (2016) Cell-of-origin-specific 3D genome structure acquired during somatic cell reprogramming. Cell Stem Cell 18:597–610

[61] Laugesen A, Helin K (2014) Chromatin repressive complexes in stem cells, development, and cancer. Cell Stem Cell 14:735–751

[62] Lemaitre C, Bickmore WA (2015) Chromatin at the nuclear periphery and the regulation of genome functions. Histochem Cell Biol 144:111–122

[63] Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S, Scholer HR, Tomilin A, Jaenisch R (2007) Oct4 expression is not required for mouse somatic stem cell selfrenewal. Cell Stem Cell 1:403–415

[64] Li A, Zhou T, Guo L, Si J (2010) Collagen type I regulates betacatenin tyrosine phosphorylation and nuclear translocation to promote migration and proliferation of gastric carcinoma cells. Oncol Rep 23:1247–1255

[65] Li X, Zhou B, Chen L, Gou LT, Li H, Fu XD (2017) GRID-seq reveals the global RNA-chromatin interactome. Nat Biotechnol 35:940–950

[66] Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO (2009) Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326:289–293

[67] Link PA, Zhang W, Odunsi K, Karpf AR (2013) BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer. Cancer Immun 13:6

[68] Lorzadeh A, Bilenky M, Hammond C, Knapp D, Li L, Miller PH, Carles A, Heravi-Moussavi A, Gakkhar S, Moksa M (2016) Nucleosome density ChIP-seq identifies distinct chromatin modification signatures associated with MNase accessibility. Cell Rep 17:2112–2124

[69] Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA (2002) BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci USA 99:6806–6811

[70] Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153:320–334

[71] Lu X, Mazur SJ, Lin T, Appella E, Xu Y (2014) The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene 33:2655–2664

[72] Maass PG, Barutcu AR, Rinn JL (2019) Interchromosomal interactions: a genomic love story of kissing chromosomes. J Cell Biol 218:27–38

[73] Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133:704–715

[74] Manukyan M, Singh PB (2014) Epigenome rejuvenation: HP1beta mobility as a measure of pluripotent and senescent chromatin ground states. Sci Rep 4:4789

[75] Marucci L, Pedone E, Di Vicino U, Sanuy-Escribano B, Isalan M, Cosma MP (2014) beta-Catenin fluctuates in mouse ESCs and is essential for Nanog-mediated reprogramming of somatic cells to pluripotency. Cell Rep 8:1686–1696

[76] McDonald OG, Wu H, Timp W, Doi A, Feinberg AP (2011) Genomescale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol 18:867–874

[77] Medema JP (2013) Cancer stem cells: the challenges ahead. Nat Cell Biol 15:338–344

[78] Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T (2006) Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 10:105–116

[79] Misteli T (2020) The self-organizing genome: principles of genome architecture and function. Cell 183:28–45

[80] Monahan K, Horta A, Lomvardas S (2019) LHX2- and LDB1- mediated trans interactions regulate olfactory receptor choice. Nature 565:448–453

[81] Mumbach MR, Rubin AJ, Flynn RA, Dai C, Khavari PA, Greenleaf WJ, Chang HY (2016) HiChIP: efficient and sensitive analysis of protein-directed genome architecture. Nat Methods 13:919–922

[82] Nacht AS, Ferrari R, Zaurin R, Scabia V, Carbonell-Caballero J, Le Dily F, Quilez J, Leopoldi A, Brisken C, Beato M (2019) C/EBPalpha mediates the growth inhibitory effect of progestins on breast cancer cells. EMBO J 38:e101426

[83] Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N, Piolot T, van Berkum NL, Meisig J, Sedat J (2012) Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 485:381–385

[84] Nora EP, Goloborodko A, Valton AL, Gibcus JH, Uebersohn A, Abdennur N, Dekker J, Mirny LA, Bruneau BG (2017) Targeted degradation of CTCF decouples local insulation of chromosome domains from genomic compartmentalization. Cell 169:930–944

[85] Novo CL, Javierre BM, Cairns J, Segonds-Pichon A, Wingett SW, Freire-Pritchett P, Furlan-Magaril M, Schoenfelder S, Fraser P, Rugg-Gunn PJ (2018) Long-range enhancer interactions are prevalent in mouse embryonic stem cells and are reorganized upon pluripotent state transition. Cell Rep 22:2615–2627

[86] Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39:237–242

[87] Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T (2014) Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 156:663–677

[88] Osmanagic-Myers S, Dechat T, Foisner R (2015) Lamins at the crossroads of mechanosignaling. Genes Dev 29:225–237

[89] Pagliara S, Franze K, McClain CR, Wylde G, Fisher CL, Franklin RJM, Kabla AJ, Keyser UF, Chalut KJ (2014) Auxetic nuclei in embryonic stem cells exiting pluripotency. Nat Mater 13:638–644

[90] Pajerowski JD, Dahl KN, Zhong FL, Sammak PJ, Discher DE (2007) Physical plasticity of the nucleus in stem cell differentiation. Proc Natl Acad Sci USA 104:15619–15624

[91] Papp B, Plath K (2013) Epigenetics of reprogramming to induced pluripotency. Cell 152:1324–1343

[92] Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SW, Solovei I, Brugman W, Graf S, Flicek P, Kerkhoven RM, van Lohuizen M (2010) Molecular maps of the reorganization of genomenuclear lamina interactions during differentiation. Mol Cell 38:603–613

[93] Plotnikov EY, Babenko VA, Silachev DN, Zorova LD, Khryapenkova TG, Savchenko ES, Pevzner IB, Zorov DB (2015) Intercellular transfer of mitochondria. Biochemistry 80:542–548

[94] Pujadas E, Feinberg AP (2012) Regulated noise in the epigenetic landscape of development and disease. Cell 148:1123–1131

[95] Ray J, Munn PR, Vihervaara A, Lewis JJ, Ozer A, Danko CG, Lis JT (2019) Chromatin conformation remains stable upon extensive transcriptional changes driven by heat shock. Proc Natl Acad Sci USA 116:19431–19439

[96] Rubin AJ, Barajas BC, Furlan-Magaril M, Lopez-Pajares V,Mumbach MR, Howard I, Kim DS, Boxer LD, Cairns J, Spivakov M (2017) Lineage-specific dynamic and pre-established enhancer-promoter contacts cooperate in terminal differentiation. Nat Genet 49:1522–1528

[97] Saldana-Meyer R, Rodriguez-Hernaez J, Escobar T, Nishana M, Jacome-Lopez K, Nora EP, Bruneau BG, Tsirigos A, Furlan- MMagaril J, Skok (2019) RNA interactions are essential for CTCF-mediated genome organization. Mol Cell 76:412–422

[98] Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39:232–236

[99] Schlesinger S, Kaffe B, Melcer S, Aguilera JD, Sivaraman DM, Kaplan T, Meshorer E (2017) A hyperdynamic H3.3 nucleosome marks promoter regions in pluripotent embryonic stem cells. Nucleic Acids Res 45:12181–12194

[100] Shahzad U, Li C, Johnston M, Wang JJ, Sabha N, Varn FS, Riemenschneider A, Krumholtz S, Meda P, Smith CA (2020) CASCADES, a novel SOX2 super-enhancer associated long noncoding RNA, regulates cancer stem cell specification and differentiation in glioblastoma multiforme. bioRxiv. https://doi.org/10.1101/2020.09.05.284349

[101] Shakya A, Callister C, Goren A, Yosef N, Garg N, Khoddami V, Nix D, Regev A, Tantin D (2015) Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion. Mol Cell Biol 35:1014–1025

[102] Shan J, Shen J, Liu L, Xia F, Xu C, Duan G, Xu Y, Ma Q, Yang Z, Zhang Q (2012) Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma. Hepatology 56:1004–1014

[103] Shibata H, Komura S, Yamada Y, Sankoda N, Tanaka A, Ukai T, Kabata M, Sakurai S, Kuze B, Woltjen K (2018) In vivo reprogramming drives Kras-induced cancer development. Nat Commun 9:2081

[104] Sigova AA, Abraham BJ, Ji X, Molinie B, Hannett NM, Guo YE, Jangi M, Giallourakis CC, Sharp PA, Young RA (2015) Transcription factor trapping by RNA in gene regulatory elements. Science 350:978–981

[105] Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28:3949–3959

[106] Spitz F, Furlong EE (2012) Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 13:613–626

[107] Stevens TJ, Lando D, Basu S, Atkinson LP, Cao Y, Lee SF, Leeb M, Wohlfahrt KJ, Boucher W, O’Shaughnessy-Kirwan A (2017) 3D structures of individual mammalian genomes studied by single-cell Hi-C. Nature 544:59–64

[108] Szabo Q, Donjon A, Jerkovic I, Papadopoulos GL, Cheutin T, Bonev B, Nora EP, Bruneau BG, Bantignies F, Cavalli G (2020) Regulation of single-cell genome organization into TADs and chromatin nanodomains. Nat Genet 52:1151–1157

[109] Therizols P, Illingworth RS, Courilleau C, Boyle S, Wood AJ, Bickmore WA (2014) Chromatin decondensation is sufficient to alter nuclear organization in embryonic stem cells. Science 346:1238–1242

[110] Timp W, Bravo HC, McDonald OG, Goggins M, Umbricht C, Zeiger M, Feinberg AP, Irizarry RA (2014) Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors. Genome Med 6:61

[111] Towbin BD, Gonzalez-Aguilera C, Sack R, Gaidatzis D, Kalck V, Meister P, Askjaer P, Gasser SM (2012) Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery. Cell 150:934–947

[112] Underwood JM, Becker KA, Stein GS, Nickerson JA (2017) The ultrastructural signature of human embryonic stem cells. J Cell Biochem 118:764–774

[113] van Steensel B, Belmont AS (2017) Lamina-associated domains: links with chromosome architecture, heterochromatin, and gene repression. Cell 169:780–791

[114] Vian L, Pekowska A, Rao SSP, Kieffer-Kwon KR, Jung S, Baranello L, Huang SC, El Khattabi L, Dose M, Pruett N (2018) The energetics and physiological impact of cohesin extrusion. Cell 173:1165–1178

[115] Wang Y, Liu Y, Malek SN, Zheng P, Liu Y (2011) Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies. Cell Stem Cell 8:399–411

[116] Wang MC, Jiao M, Wu T, Jing L, Cui J, Guo H, Tian T, Ruan ZP, Wei YC, Jiang LL (2016) Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study. Oncotarget 7:9586–9599

[117] Wang H, Xu X, Nguyen CM, Liu Y, Gao Y, Lin X, Daley T, Kipniss NH, La Russa M, Qi LS (2018) CRISPR-mediated programmable 3D genome positioning and nuclear organization. Cell 175:1405–1417

[118] Wang B, Kong L, Babu D, Choudhary R, Fam W, Tng JQ, Goh Y, Liu X, Song FF, Chia P (2020) Three-dimensional genome organization maps in normal haematopoietic stem cells and acute myeloid leukemia. bioRxiv. https://doi.org/10.1101/2020.04.18.047738

[119] Wei X, Xiang Y, Abnousi A, Sun T, Lin X, Li W, Hu M, Diao Y (2020) HiCAR: a robust and sensitive multi-omic co-assay for simultaneous measurement of transcriptome, chromatin accessibility, and cis-regulatory chromatin contacts. bioRxiv. https://doi.org/10.1101/2020.11.02.366062

[120] Weintraub AS, Li CH, Zamudio AV, Sigova AA, Hannett NM, Day DS, Abraham BJ, Cohen MA, Nabet B, Buckley DL (2017) YY1 Is a structural regulator of enhancer-promoter loops. Cell 171:1573–1588

[121] Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP (2009) Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 41:246–250

[122] Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, Rahl PB, Lee TI, Young RA (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153:307–319

[123] Xiong X, Schober M, Tassone E, Khodadadi-Jamayran A, Sastre-Perona A, Zhou H, Tsirigos A, Shen S, Chang M, Melamed J (2018) KLF4, a gene regulating prostate stem cell homeostasis, is a barrier to malignant progression and predictor of good prognosis in prostate cancer. Cell Rep 25:3006–3020

[124] Yochum GS, Sherrick CM, Macpartlin M, Goodman RH (2010) A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5’ and 3’ Wnt responsive enhancers. Proc Natl Acad Sci USA 107:145–150

[125] You JS, Jones PA (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22:9–20

[126] Zhang H, Li H, Xi HS, Li S (2012) HIF1alpha is required for survival maintenance of chronic myeloid leukemia stem cells. Blood 119:2595–2607

[127] Zhu J, Adli M, Zou JY, Verstappen G, Coyne M, Zhang X, Durham T, Miri M, Deshpande V, De Jager PL (2013) Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 152:642

RIGHTS & PERMISSIONS

2021 The Author(s)